| 000 | 01714 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516013204.0 | ||
| 264 | 0 | _c20110321 | |
| 008 | 201103s 0 0 eng d | ||
| 022 | _a1879-0070 | ||
| 024 | 7 |
_a10.1016/j.diagmicrobio.2010.09.018 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBiedenbach, Douglas J | |
| 245 | 0 | 0 |
_aStability of linezolid activity in an era of mobile oxazolidinone resistance determinants: results from the 2009 Zyvox® Annual Appraisal of Potency and Spectrum program. _h[electronic resource] |
| 260 |
_bDiagnostic microbiology and infectious disease _cDec 2010 |
||
| 300 |
_a459-67 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetamides _xpharmacology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Infective Agents _xpharmacology |
| 650 | 0 | 4 |
_aBacterial Proteins _xgenetics |
| 650 | 0 | 4 |
_aDrug Resistance, Multiple, Bacterial _xgenetics |
| 650 | 0 | 4 | _aGlobal Health |
| 650 | 0 | 4 |
_aGram-Positive Bacterial Infections _xepidemiology |
| 650 | 0 | 4 |
_aGram-Positive Cocci _xclassification |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLinezolid |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMicrobial Sensitivity Tests _xmethods |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOxazolidinones _xpharmacology |
| 650 | 0 | 4 |
_aPopulation Surveillance _xmethods |
| 650 | 0 | 4 | _aSpecies Specificity |
| 700 | 1 | _aFarrell, David J | |
| 700 | 1 | _aMendes, Rodrigo E | |
| 700 | 1 | _aRoss, James E | |
| 700 | 1 | _aJones, Ronald N | |
| 773 | 0 |
_tDiagnostic microbiology and infectious disease _gvol. 68 _gno. 4 _gp. 459-67 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.diagmicrobio.2010.09.018 _zAvailable from publisher's website |
| 999 |
_c20390612 _d20390612 |
||